• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在既往有盆腔手术史的女性中,我们是否低估了膀胱内注射肉毒毒素 A 后发生尿潴留的风险?

Are we underestimating urinary retention following intravesical onabotulinumtoxinA in women with overactive bladder and a history of prior pelvic surgery?

机构信息

Department of Urological Surgery, Barwon Health, University Hospital Geelong, Geelong, Victoria, Australia.

Department of Biostatistics, Deakin University, Geelong, Victoria, Australia.

出版信息

Neurourol Urodyn. 2023 Jan;42(1):106-112. doi: 10.1002/nau.25054. Epub 2022 Oct 2.

DOI:10.1002/nau.25054
PMID:36183370
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10092604/
Abstract

AIMS

This study's purpose is to review the rates of urinary retention requiring intermittent catheterization (IC) post intravesical OnabotulinumtoxinA (BTN/A) injection for idiopathic overactive bladder from a single practicing specialist urological surgeon.

METHODS

We performed a retrospective review of a single Australian urologist to identify the rate of intermittent catheterization in our clinical setting. Logistic regression was used to assess associations between requirement of IC and risk factors for urinary retention.

RESULTS

Ninety-four patients were included after inclusion and exclusion criteria were applied and the average age was 69.7 years (SD 17.2) and all participants were female. Thirty-six percent (n = 34) of patients required IC. Of patients requiring IC, 32% had a prior urethral sling, 35% had prior vaginal prolapse surgery, and 29% had a preoperative urinary tract infection (UTI). There was strong evidence of univariate associations between IC and prior sling (odds ratio [OR]: 5.26, 95% confidence interval [CI]: 1.64-16.55, p = 0.005), preoperative UTI (OR: 4.25, 95% CI: 1.31-13.08, p = 0.016) and prior vaginal prolapse surgery (OR: 4.91, 95% CI: 1.64-14.72, p = 0.005). Evidence that prior sling patients were more likely to require IC remained strong in a multivariable model (OR: 7.35, 95% CI: 1.59-34.11, p = 0.011).

CONCLUSION

Prior urethral sling surgery, prior vaginal prolapse surgery, and positive preoperative UTI, despite treatment, were found to be associated with a higher rate of initiation of intermittent catheterization. The rate of IC initiation of 36% was higher than reported in prior clinical trials.

摘要

目的

本研究旨在回顾一位澳大利亚泌尿科专家的临床实践中,膀胱内注射奥昔布宁毒素 A(BTN/A)后发生尿潴留需要间歇性导尿(IC)的发生率。

方法

我们对一位澳大利亚泌尿科医生进行了回顾性分析,以确定我们临床环境中 IC 的发生率。使用逻辑回归评估 IC 需求与尿潴留风险因素之间的关联。

结果

应用纳入和排除标准后,共纳入 94 名患者,平均年龄为 69.7 岁(标准差 17.2),所有患者均为女性。36%(n=34)的患者需要 IC。需要 IC 的患者中,32%有先前的尿道吊带术,35%有先前的阴道脱垂手术,29%有术前尿路感染(UTI)。IC 与先前吊带术(优势比[OR]:5.26,95%置信区间[CI]:1.64-16.55,p=0.005)、术前 UTI(OR:4.25,95%CI:1.31-13.08,p=0.016)和先前阴道脱垂手术(OR:4.91,95%CI:1.64-14.72,p=0.005)之间存在很强的单变量关联。在多变量模型中,先前吊带术患者更有可能需要 IC 的证据仍然很强(OR:7.35,95%CI:1.59-34.11,p=0.011)。

结论

尽管进行了治疗,但先前的尿道吊带术、先前的阴道脱垂手术和术前阳性 UTI 与更高的间歇性导尿起始率相关。IC 起始率为 36%,高于先前临床试验报道的起始率。

相似文献

1
Are we underestimating urinary retention following intravesical onabotulinumtoxinA in women with overactive bladder and a history of prior pelvic surgery?在既往有盆腔手术史的女性中,我们是否低估了膀胱内注射肉毒毒素 A 后发生尿潴留的风险?
Neurourol Urodyn. 2023 Jan;42(1):106-112. doi: 10.1002/nau.25054. Epub 2022 Oct 2.
2
Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome.临床实践中膀胱内注射A型肉毒杆菌毒素治疗特发性膀胱过度活动症后的尿潴留发生率及该结果的预测因素。
Neurourol Urodyn. 2015 Sep;34(7):675-8. doi: 10.1002/nau.22642. Epub 2014 Jun 29.
3
Real-World Retention Rates After Intravesical OnabotulinumtoxinA for Idiopathic Overactive Bladder.膀胱内注射A型肉毒毒素治疗特发性膀胱过度活动症后的真实世界保留率
Female Pelvic Med Reconstr Surg. 2018 Nov/Dec;24(6):404-407. doi: 10.1097/SPV.0000000000000496.
4
Clean intermittent catheterization rates after initial and subsequent treatments with onabotulinumtoxinA for non-neurogenic overactive bladder in real-world clinical settings.在真实临床环境中,非神经源性逼尿症患者首次和后续接受肉毒毒素 A 治疗后的间歇性清洁导尿率。
Curr Med Res Opin. 2018 Oct;34(10):1771-1776. doi: 10.1080/03007995.2018.1443061. Epub 2018 Mar 20.
5
Incomplete bladder emptying and urinary tract infections after botulinum toxin injection for overactive bladder: Multi-institutional collaboration from the SUFU research network.在治疗膀胱过度活动症的肉毒毒素注射后出现不完全排空膀胱和尿路感染:来自 SUFU 研究网络的多机构合作。
Neurourol Urodyn. 2022 Feb;41(2):662-671. doi: 10.1002/nau.24871. Epub 2022 Jan 12.
6
Routine Office Assessment After OnabotulinumtoxinA Injection for Overactive Bladder Is Unnecessary to Detect Clinically Significant Voiding Dysfunction.常规办公评估在治疗膀胱过度活动症的肉毒毒素 A 注射后对检测有临床意义的排尿功能障碍是不必要的。
Female Pelvic Med Reconstr Surg. 2021 Apr 1;27(4):225-229. doi: 10.1097/SPV.0000000000001001.
7
The Correlation of Diabetes Mellitus and Urinary Retention From Intravesical OnabotulinumtoxinA Injection for Overactive Bladder.糖尿病与膀胱内注射肉毒毒素 A 治疗膀胱过度活动症后尿潴留的相关性。
Urogynecology (Phila). 2023 May 1;29(5):511-519. doi: 10.1097/SPV.0000000000001297. Epub 2022 Nov 21.
8
What is the true catheterization rate after intravesical onabotulinumtoxinA injection?膀胱内注射A型肉毒杆菌毒素后的实际导尿率是多少?
Int Urogynecol J. 2018 Jul;29(7):1005-1009. doi: 10.1007/s00192-017-3440-2. Epub 2017 Aug 14.
9
Antibiotic regimen and route of administration do not alter rates of urinary tract infection after intravesical botulinum toxin injection for overactive bladder.膀胱内注射肉毒杆菌毒素治疗膀胱过度活动症后,抗生素治疗方案和给药途径不会改变尿路感染的发生率。
Int Urogynecol J. 2022 Mar;33(3):703-709. doi: 10.1007/s00192-021-04691-4. Epub 2021 Feb 16.
10
Predictors for adverse events following intravesical botulinum toxin injections in men.男性膀胱内注射肉毒毒素后不良事件的预测因素。
Neurourol Urodyn. 2023 Sep;42(7):1499-1505. doi: 10.1002/nau.25230. Epub 2023 Jun 29.

引用本文的文献

1
Variation in the Definitions of Urinary Retention in Studies of Intravesical Botulinum Toxin for Idiopathic Overactive Bladder: A Narrative Systematic Review.肉毒杆菌毒素治疗特发性膀胱过度活动症研究中尿潴留定义的差异:一项叙述性系统评价
Neurourol Urodyn. 2025 Apr;44(4):860-877. doi: 10.1002/nau.70017. Epub 2025 Feb 17.

本文引用的文献

1
Botulinum toxin A for the Treatment of Overactive Bladder.A型肉毒杆菌毒素治疗膀胱过度活动症
Toxins (Basel). 2016 Feb 29;8(3):59. doi: 10.3390/toxins8030059.
2
Urinary retention rates after intravesical onabotulinumtoxinA injection for idiopathic overactive bladder in clinical practice and predictors of this outcome.临床实践中膀胱内注射A型肉毒杆菌毒素治疗特发性膀胱过度活动症后的尿潴留发生率及该结果的预测因素。
Neurourol Urodyn. 2015 Sep;34(7):675-8. doi: 10.1002/nau.22642. Epub 2014 Jun 29.
3
OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.肉毒杆菌毒素 A 100U 显著改善伴有尿急和尿失禁的膀胱过度活动症患者的所有特发性膀胱过度活动症症状和生活质量:一项随机、双盲、安慰剂对照试验。
Eur Urol. 2013 Aug;64(2):249-56. doi: 10.1016/j.eururo.2013.04.001. Epub 2013 Apr 10.
4
OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.肉毒杆菌毒素 A 治疗膀胱过度活动症伴尿失禁患者:一项 3 期、随机、安慰剂对照试验的结果。
J Urol. 2013 Jun;189(6):2186-93. doi: 10.1016/j.juro.2012.12.022. Epub 2012 Dec 14.
5
Treatment of mixed urinary incontinence in women.女性混合性尿失禁的治疗。
Curr Opin Obstet Gynecol. 2011 Oct;23(5):371-5. doi: 10.1097/GCO.0b013e32834a9298.
6
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence.第四届尿失禁国际咨询会:国际科学委员会的建议:尿失禁、盆腔器官脱垂及大便失禁的评估与治疗
Neurourol Urodyn. 2010;29(1):213-40. doi: 10.1002/nau.20870.
7
Refractory idiopathic urge urinary incontinence and botulinum A injection.难治性特发性急迫性尿失禁与A型肉毒毒素注射
J Urol. 2008 Jul;180(1):217-22. doi: 10.1016/j.juro.2008.03.028. Epub 2008 May 21.
8
The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study.膀胱过度活动症、尿失禁及其他下尿路症状对男性和女性生活质量、工作效率、性功能及情绪健康的影响:EPIC研究结果
BJU Int. 2008 Jun;101(11):1388-95. doi: 10.1111/j.1464-410X.2008.07601.x.
9
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.五个国家基于人群的尿失禁、膀胱过度活动症及其他下尿路症状调查:EPIC研究结果
Eur Urol. 2006 Dec;50(6):1306-14; discussion 1314-5. doi: 10.1016/j.eururo.2006.09.019. Epub 2006 Oct 2.
10
How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study.膀胱过度活动症的症状有多普遍,以及如何进行管理?一项基于人群的患病率研究。
BJU Int. 2001 Jun;87(9):760-6. doi: 10.1046/j.1464-410x.2001.02228.x.